These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36227664)
1. Expression of CD123 Related Long Non-coding RNA in Acute Myeloid Leukemia Bone Marrow Mononuclear Cells and Its Clinical Significance. Feng Y; Su B; Xu Y; He Y; He R; Ge F Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):140-147. PubMed ID: 36227664 [TBL] [Abstract][Full Text] [Related]
2. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia. Zheng J; Song Y; Li Z; Tang A; Fei Y; He W Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697 [TBL] [Abstract][Full Text] [Related]
3. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients. Aref S; Azmy E; El Ghannam D; Haroun M; Ibrahim L; Sabry M Cancer Biomark; 2020; 29(1):9-16. PubMed ID: 32417762 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia. Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333 [TBL] [Abstract][Full Text] [Related]
5. Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients. Cao L; Xiao PF; Tao YF; Hu SY; Lu J; Zhao WL; Li ZH; Wang NN; Wang J; Feng X; Chai YH; Pan J; Gu GX Oncol Rep; 2016 Feb; 35(2):757-70. PubMed ID: 26573779 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk. Wang Y Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197 [TBL] [Abstract][Full Text] [Related]
7. A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia. Xu S; Zhang M; Fang X; Meng J; Xing H; Yan D; Liu J; Yang Y; Wen T; Zhang W; Wang J; Wang C; Xu H J Hematol Oncol; 2021 Nov; 14(1):193. PubMed ID: 34774070 [TBL] [Abstract][Full Text] [Related]
8. Revealing key lncRNAs in cytogenetically normal acute myeloid leukemia by reconstruction of the lncRNA-miRNA-mRNA network. Sun T; Dong L; Guo Y; Zhao H; Wang M Sci Rep; 2022 Mar; 12(1):4973. PubMed ID: 35322118 [TBL] [Abstract][Full Text] [Related]
9. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations. Rollins-Raval M; Pillai R; Warita K; Mitsuhashi-Warita T; Mehta R; Boyiadzis M; Djokic M; Kant JA; Roth CG Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610 [TBL] [Abstract][Full Text] [Related]
10. [The study of expression and prognostic value of CD123 in acute myeloid leukemia bone marrow blasts]. Yue WQ; Tang GS; Liu M; Cheng H; Ding J; Wang T; Wang JM; Hu XX; Zhang WP; Chen L; Yang JM Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):876-882. PubMed ID: 29166741 [No Abstract] [Full Text] [Related]
11. LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A. Zhou W; Xu S; Deng T; Zhou R; Wang C Hum Cell; 2022 Jan; 35(1):360-378. PubMed ID: 34694569 [TBL] [Abstract][Full Text] [Related]
12. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients]. Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374 [No Abstract] [Full Text] [Related]
13. [Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype]. Zhang Y; Liu RY; Wang SJ; Wang C; Zhang QT; He C; Xie XS; Wan DM; Jiang ZX; Liu YF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1880-1884. PubMed ID: 33283714 [TBL] [Abstract][Full Text] [Related]
14. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group. Lamble AJ; Eidenschink Brodersen L; Alonzo TA; Wang J; Pardo L; Sung L; Cooper TM; Kolb EA; Aplenc R; Tasian SK; Loken MR; Meshinchi S J Clin Oncol; 2022 Jan; 40(3):252-261. PubMed ID: 34855461 [TBL] [Abstract][Full Text] [Related]
15. CD123-targeted therapy in acute myeloid leukemia. Espinoza-Gutarra MR; Green SD; Zeidner JF; Konig H Expert Rev Hematol; 2021 Jun; 14(6):561-576. PubMed ID: 34043467 [TBL] [Abstract][Full Text] [Related]
16. Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population. Leyton JV; Hu M; Gao C; Turner PV; Dick JE; Minden M; Reilly RM J Nucl Med; 2011 Sep; 52(9):1465-73. PubMed ID: 21816968 [TBL] [Abstract][Full Text] [Related]
17. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Bonifant CL; Szoor A; Torres D; Joseph N; Velasquez MP; Iwahori K; Gaikwad A; Nguyen P; Arber C; Song XT; Redell M; Gottschalk S Mol Ther; 2016 Sep; 24(9):1615-26. PubMed ID: 27401038 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia. Zhou H; Jia X; Yang F; Shi P Bioengineered; 2021 Dec; 12(1):6403-6417. PubMed ID: 34516354 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia. Kandeel EZ; Madney Y; Eldin DN; Shafik NF Exp Mol Pathol; 2021 Feb; 118():104597. PubMed ID: 33358743 [TBL] [Abstract][Full Text] [Related]
20. [Expression and Clinical Significance of Leukemia Stem Cell Antigen in Acute Myeloid Leukemia]. Yao DD; Han BQ; Han YF; Zhang YQ; Jin YL; Dai HB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1583-1588. PubMed ID: 30501688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]